Average Co-Inventor Count = 5.64
ph-index = 10
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Bristol-myers Squibb Compnay (31 from 3,684 patents)
2. Bristol-myers Squibb Pharma Company (21 from 234 patents)
3. Other (2 from 832,843 patents)
4. Bristol-myers Squibb Pharma Corporation (1 from 10 patents)
55 patents:
1. 12492202 - Macrocyclic PAD4 inhibitors useful as immunosuppressant
2. 12473304 - Heterocyclic PAD4 inhibitors
3. 11981680 - Substituted thienopyrroles as PAD4 inhibitors
4. 11299494 - Substituted imidazo[1,2-b]pyridazines as interleukin-23 and interferon-α modulators
5. 10618903 - Heteroaryl substituted aminopyridine compounds
6. 10544133 - Heteroaryl substituted pyridyl compounds useful as kinase modulators
7. 10294229 - Heteroaryl substituted aminopyridine compounds
8. 10294256 - Phosphine oxide alkyl amide substituted heteroaryl compounds as modulators of IL-12, IL-23 and/or IFN alpha responses
9. 10202390 - Heteroaryl substituted aminopyridine compounds
10. 10023562 - Heteroaryl substituted pyridyl compounds useful as kinase modulators
11. 9657009 - Heteroaryl substituted pyridyl compounds useful as kinase modulators
12. 9546153 - Bicyclic heterocycle substituted pyridyl compounds useful as kinase modulators
13. 9221819 - Spirocyclic compounds as modulators of chemokine receptor activity
14. 9169252 - Heteroaryl substituted nicotinamide compounds
15. 8877749 - Spirocyclic compounds as modulators of chemokine receptor activity